Liver Disease in Pregnancy: A Prospective Analysis of Maternal and Fetal Outcomes among 120 Patients at a Tertiary Care Center
Shruti A Panchbudhe, Maitreyee Parulekar, Supriya Kudale
HELLP syndrome, Hepatitis E in pregnancy, Liver disease in pregnancy, maternal and fetal outcomes
Citation Information :
Panchbudhe SA, Parulekar M, Kudale S. Liver Disease in Pregnancy: A Prospective Analysis of Maternal and Fetal Outcomes among 120 Patients at a Tertiary Care Center. J South Asian Feder Obs Gynae 2022; 14 (5):551-556.
Background: Liver disorders during pregnancy pose unique challenges to the managing obstetrician in terms of consequences to the mother and the fetus. The aim of the study is to evaluate the various etiologies, clinical presentation, and to find out the maternal and fetal outcomes in mothers presenting with liver disorders during pregnancy.
Methods: The study prospectively analyzed 120 consecutive patients who presented to our tertiary care center and were diagnosed to have some liver disease based on a combination of clinical, serological, or radiological evidence. Patients with liver disorder secondary to sepsis and multiorgan failure were excluded from the study.
Results: A maximum number of patients were in the age group of 21–30 (73.3%). In terms of frequency, most common liver disorder was hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome (21.7%) cases followed by pre-eclampsia (19.2%) and Hepatitis E (14.2%). There was high presence of preterm deliveries comprising 64.25% of all deliveries. There were 107 live births and still birth was noted in 13 patients. Among the still birth group, the most common associated liver disease was Hepatitis E in 10 (76.9%) patients. The maternal mortality was 13.3% (16 patients). Hepatitis E was the single most important cause of mortality in all 16 patients.
Conclusion: Pregnancy-specific liver disorders were far more common in the study and HELLP syndrome accounted for maximum number of cases. The presence of hepatitis E was the single most important cause of both fetal and maternal mortality.
Solanke D, Rathi C, Pandey V, et al. Etiology, clinical profile, and outcome of liver disease in pregnancy with predictors of maternal mortality: A prospective study from Western India. Indian J Gastroenterol 2016;35(6):450–458. DOI: 10.1007/s12664-016- 0704-6.
Alghamdi S, Fleckenstein J. Liver disease in pregnancy and transplant. Curr Gastroenterol Rep 2019;21(9):43. DOI: 10.1007/s11894-019-0711-8.
Lao TT. Implications of abnormal liver function in pregnancy and non-alcoholic fatty liver disease. Best Pract Res Clin Obstet Gynaecol 2020;68:2–11. DOI: 10.1016/j.bpobgyn.2020.02.011.
Bacq Y, Zarka O, Bréchot JF, et al. Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology 1996;23(5):1030–1034. DOI: 10.1002/hep.510230514.
Girling JC, Dow E, Smith JH. Liver function tests in pre-eclampsia: importance of comparison with a reference range derived for normal pregnancy. Br J Obstet Gynaecol 1997;104(2):246–250. DOI: 10.1111/j.1471-0528.1997.tb11054.x.
Sookoian S. Effect of pregnancy on pre-existing liver disease: chronic viral hepatitis. Ann Hepatol 2006;5(3):190–197. PMID: 17060881.
Borgia G, Carleo MA, Gaeta GB, et al. Hepatitis B in pregnancy. World J Gastroenterol 2012;18(34):4677–4683. DOI: 10.3748/wjg.v18.i34.4677.
Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol. 2016;64(4):933–945. DOI: 10.1016/j.jhep.2015.11.030.
Matin A, Sass DA. Liver disease in pregnancy. Gastroenterol Clin North Am 2011;40(2):335–353. DOI: 10.1016/j.gtc.2011.03.010.
Ch'ng CL, Morgan M, Hainsworth I, et al. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002;51:876–880. DOI: 10.1136/gut.51.6.876.
Devarbhavi H, Kremers WK, Dierkhising R, et al. Pregnancy associated acute liver disease and acute viral hepatitis: differentiation, course and outcome. J Hepatol 2008;49:930–935. PMID: 18926590.
Tiwari, A, Aditya, V, Srivastava, R, et al. A study of spectrum and outcome of liver diseases in pregnant women at BRD medical college. Int J Reprod Contracept Obstet Gynecol 2017;6(8):3641–3645. http://dx.doi.org/10.18203/2320-1770.ijrcog20173501.
Sharma S, Aherwar R, Jawade S. Maternal and fetal outcome in jaundice complicating pregnancy: a prospective study. Int J Reprod Contracept Obstet Gynecol 2016;5:1084–1087. DOI: 10.18203/2320-1770.ijrcog20160862.
Jain M, Thaker H. A study of fetomaternal outcome of hepatic disorders in pregnancy. Int J Reprod Contracept Obstet Gynecol 2019;8: 1182–1185. https://dx.doi.org/10.18203/2320-1770.ijrcog20190902.
Rathi U, Bapat M, Rathi P, et al. Effect of liver disease on maternal and fetal outcome-a prospective study. Indian J Gastroenterol 2007;26(2):59. Corpus ID: 32922046.
Ramola M, Jain S, Gupta V, et al. Overview of liver disorders during pregnancy at a tertiary care centre: Uttarakhand scenario. Int J Reprod Contracept Obstet Gynecol 2017;6:3979–3982. https://dx.doi.org/10.18203/2320-1770.ijrcog20174048.
Konareddy T, Krithika KA. Jaundice in pregnancy, a clinical study at JSS hospital, Mysore, Karnataka, India. Int J Reprod Contracept Obstet Gynaecol. 2016;5:2257–2260. https://dx.doi.org/10.18203/2320-1770.ijrcog20162105.
Garg R, Nigam A, Singh S, et al. Seroprevalence of hepatitis b surface antigen among pregnant women in a Tertiary Care Health Center of North India. J South Asian Feder Obs Gynae 2017;9(2):164–168. https://dx.doi.org/10.5005/jp-journals-10006-1484.
Prakash P, Kumari SS, Agarwal P. Hepatitis B in pregnancy. J South Asian Feder Obs Gynae 2016;8(3):167–170. DOI: 10.5005/jp- journals-10006-1410.